Document Detail


Comprehensibility, reliability, validity, and responsiveness of the Thai version of the Health Assessment Questionnaire in Thai patients with rheumatoid arthritis.
MedLine Citation:
PMID:  19709443     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: The Health Assessment Questionnaire Disability Index (HAQ-DI) is a commonly used instrument to assess functional status of patients with rheumatoid arthritis (RA). Translations and adaptations of the HAQ-DI have been carried out for use with RA patients in several countries. The objective of this study was to evaluate the psychometric properties of the Thai version of the HAQ-DI (Thai HAQ) in Thai patients with RA. METHODS: Comprehensibility of the Thai HAQ was assessed by 126 patients with RA from 6 medical centers in Thailand. Another group of 115 patients with active RA was enrolled to test the reliability (internal reliability and 1-week test-retest reliability), construct validity (correlations with other measures of RA disease activity), floor and ceiling effects, and sensitivity to change of the Thai HAQ at 3 months of treatment with disease-modifying antirheumatic drugs. RESULTS: More than 98% of the patients regarded the Thai HAQ as comprehensible. The internal consistency of the Thai HAQ was satisfactory with the overall Cronbach alpha of 0.91. The test-retest reliability of the Thai HAQ was acceptable with the intraclass correlation coefficient of 0.89. Moderate correlations between the Thai HAQ and other outcomes of RA disease activity were observed, except erythrocyte sedimentation rate, with the Spearman correlation coefficients ranging from 0.42 to 0.57. The responsiveness of the Thai HAQ was moderate, with a standardized response mean of 0.75 (95% confidence interval 0.56 to 0.94). CONCLUSIONS: The Thai HAQ is comprehensible, reliable, valid and sensitive to change in the evaluation of functional status of Thai patients with RA. The Thai HAQ is an essential tool to measure treatment effects and progression of disability in RA patients and should be applied in both clinical trials and routine clinical care settings.
Authors:
Manathip Osiri; Jeerapat Wongchinsri; Sitthichai Ukritchon; Punchong Hanvivadhanakul; Nuntana Kasitanon; Boonjing Siripaitoon
Related Documents :
9599313 - Salivary acidic proline-rich proteins in rheumatoid arthritis.
16391893 - Leflunomide/chloroquin combination therapy in rheumatoid arthritis: a pilot study.
12958283 - Population dynamics of persistent staphylococcus aureus isolated from the airways of cy...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Validation Studies     Date:  2009-08-27
Journal Detail:
Title:  Arthritis research & therapy     Volume:  11     ISSN:  1478-6362     ISO Abbreviation:  Arthritis Res. Ther.     Publication Date:  2009  
Date Detail:
Created Date:  2009-09-18     Completed Date:  2009-12-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154438     Medline TA:  Arthritis Res Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  R129     Citation Subset:  IM    
Affiliation:
Division of Rheumatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathumwan, Bangkok, Thailand. manathip.o@chula.ac.th
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / drug therapy,  physiopathology*
Comprehension
Female
Health Status
Health Status Indicators*
Humans
Male
Middle Aged
Psychometrics / methods*
Questionnaires*
Reproducibility of Results
Thailand
Chemical
Reg. No./Substance:
0/Antirheumatic Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research.
Next Document:  Downregulation of heat shock protein 70 protects rheumatoid arthritis fibroblast-like synoviocytes f...